Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan

Kunitoshi Iseki, Shigeru Nakai, Takahiro Shinzato, Osamu Morita, Toshio Shinoda, Kenjiro Kikuchi, Atsushi Wada, Naoki Kimata, Takashi Akiba

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Hypertension is common in chronic hemodialysis (HD) patients. However, its prevalence and determinants have not been studied in a large HD population. We analyzed the database of the Japanese Society for Dialysis Therapy (JSDT) registry, which conducts an annual survey of chronic dialysis patients throughout Japan. We compiled those who were on HD three-times per week and aged 20 years and over at the end of 2000 (JSDT standard analysis file 001). Hypertension was defined as predialysis systolic blood pressure (SBP) ≥140 mm Hg or predialysis diastolic blood pressure (DBP) ≥90 mm Hg. Adjusted odds ratios (95% confidence interval) for the determinants of hypertension were calculated by the multivariate logistic regression analysis. A total of 65 393 people (men, 60.2%; mean age ± SD, 60.9 ± 12.8 years; and mean duration of HD ± SD, 95.3 ± 74.0 months) were studied. Mean ± SD levels of SBP and DBP were 154.9 ± 23.8 mm Hg and 80.5 ± 13.7 mm Hg before the HD session. Hypertension was noted in 77.5% of patients. Prescription of antihypertensive drugs and erythropoietin was made to 60.7% and 82.0% of patients, respectively. Both SBP and DBP were higher in those who were prescribed antihypertensive drugs (mean, 160.4/81.9 mm Hg), than those without drugs (mean, 146.9/78.5 mm Hg) (in both cases P < 0.0001). Hypertension was positively associated with men (adjusted odds ratio (OR), 1.258; 95% confidence interval (CI), 1.188-1.333; P < 0.0001), age (OR, 1.004; CI, 1.001-1.006; P < 0.01), duration of HD (OR, 0.769; CI, 0.728-0.812; P < 0.0001), serum albumin (OR, 1.369; CI, 1.286-1.458; P < 0.0001), and change in body weight by dialysis session (ΔBW) (OR, 1.176; CI, 1.159-1.194; P < 0.0001), and was negatively associated with Kt/V (OR, 0.600; CI, 0.543-0.664; P < 0.0001), and hematocrit (OR, 0.964; CI, 0.959-0.970; P < 0.0001). The distribution of ΔBW was normal in shape and in about 22% of patients the range was from 4.0% to 4.9%. There was a significant positive relationship between the prevalence of hypertension and ΔBW (R2 = 0.8549). The higher the ΔBW, the more the prescription rate of antihypertensive drugs increased (R2 = 0.9102). Results showed that the prevalence of hypertension was significantly associated with volume excess and serum levels of albumin, calcium, and phosphorous in chronic HD patients. Despite the high prescription rate of antihypertensive drugs, control of blood pressure remains unsatisfactory.

Original languageEnglish
Pages (from-to)183-188
Number of pages6
JournalTherapeutic Apheresis and Dialysis
Volume11
Issue number3
DOIs
Publication statusPublished - 01-06-2007
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Hematology
  • Nephrology

Fingerprint Dive into the research topics of 'Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan'. Together they form a unique fingerprint.

  • Cite this

    Iseki, K., Nakai, S., Shinzato, T., Morita, O., Shinoda, T., Kikuchi, K., Wada, A., Kimata, N., & Akiba, T. (2007). Prevalence and determinants of hypertension in chronic hemodialysis patients in Japan. Therapeutic Apheresis and Dialysis, 11(3), 183-188. https://doi.org/10.1111/j.1744-9987.2007.00479.x